Literature DB >> 18379417

Stage IA vulvar squamous cell carcinoma: an analysis of tumor invasive characteristics and risk.

Brian J Yoder1, Irina Rufforny, Nicole A Massoll, Edward J Wilkinson.   

Abstract

Early invasive vulvar squamous cell carcinoma (SCC) with less than 1.0 mm of invasion (FIGO stage IA) has been shown to have a minimal risk of lymph node metastasis and is associated with an excellent prognosis. The prognostic significance of other histologic parameters other than depth of invasion, however, remains controversial. Seventy-eight consecutive cases of vulvar SCC having a depth of invasion of 5.0 mm or less were reviewed and the clinical outcome compared with the type of surgical excision, the presence of concurrent lymph node metastases, the depth of tumor invasion, the tumor thickness, the tumor horizontal spread, the estimated tumor volume, tumor histologic subtype, tumor histologic grade, tumor pattern of invasion, tumor multifocality, presence of perineural invasion, presence of angiolymphatic invasion and the presence of precursor lesions, including the type of vulvar intraepithelial neoplasia and presence of lichen sclerosus. The only histologic feature for predicting concurrent lymph node metastasis was tumor depth of invasion. The 3 most important features of stage IA tumors in predicting tumor recurrence were the depth of invasion, presence of SCC at the surgical margins, and the histologic grade.

Entities:  

Mesh:

Year:  2008        PMID: 18379417     DOI: 10.1097/PAS.0b013e318159a2cb

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  8 in total

1.  A fibromyxoid stromal response is associated with an infiltrative tumor morphology, perineural invasion, and lymph node metastasis in squamous cell carcinoma of the vulva.

Authors:  Susanne K Jeffus; Ashita Gehlot; Emily Holthoff; Rebecca Stone; Horace Spencer; Thomas Kelly; Steven R Post; Charles M Quick
Journal:  Am J Surg Pathol       Date:  2015-09       Impact factor: 6.394

2.  An alternative way to measure the depth of invasion of vulvar squamous cell carcinoma in relation to prognosis.

Authors:  Loes C G van den Einden; Leon F A G Massuger; Johanna K Jonkman; Peter Bult; Joanne A de Hullu; Johan Bulten
Journal:  Mod Pathol       Date:  2014-09-05       Impact factor: 7.842

3.  [Pathoanatomical preparation and reporting of specimens from precancerous lesions and carcinomas of the vulva].

Authors:  L-C Horn; K Schierle; K Klostermann; H-G Schnürch; P Hantschmann
Journal:  Pathologe       Date:  2009-02       Impact factor: 1.011

Review 4.  Squamous precursor lesions of the vulva: current classification and diagnostic challenges.

Authors:  Lien N Hoang; Kay J Park; Robert A Soslow; Rajmohan Murali
Journal:  Pathology       Date:  2016-04-23       Impact factor: 5.306

5.  Measuring the depth of invasion in vulvar squamous cell carcinoma: interobserver agreement and pitfalls.

Authors:  Anne-Floor W Pouwer; Peter Bult; Irene Otte; Michiel van der Brand; Judith van der Horst; Laurette J V Harterink; Koen K van de Vijver; Esther Guerra; Riena P Aliredjo; Steven L Bosch; Johanna M M Grefte; Saskia Zomer; Harry Hollema; Barry de Heus; Saphira Satumalaij; Patricia C Ewing-Graham; Joanna IntHout; Joanne A de Hullu; Johan Bulten
Journal:  Histopathology       Date:  2019-07-26       Impact factor: 5.087

6.  Practical Guidance for Measuring and Reporting Surgical Margins in Vulvar Cancer.

Authors:  Kim E Kortekaas; Koen K Van de Vijver; Mariëtte I E van Poelgeest; C Blake Gilks; Vincent T H B M Smit; Saimah Arif; Deep Arora; Asma Faruqi; Raji Ganesan; Nicholas R Griffin; Richard Hale; Yelin E Hock; Lars-Christian Horn; W Glenn McCluggage; Pinias Mukonoweshuro; Kay J Park; Brian Rous; Bruce Tanchel; Anne-Sophie Van Rompuy; Gerry van Schalkwyk; Jo Vella; Marco Vergine; Naveena Singh; Tjalling Bosse
Journal:  Int J Gynecol Pathol       Date:  2020-09       Impact factor: 3.326

Review 7.  Is There a Place for Immune Checkpoint Inhibitors in Vulvar Neoplasms? A State of the Art Review.

Authors:  Fulvio Borella; Mario Preti; Luca Bertero; Giammarco Collemi; Isabella Castellano; Paola Cassoni; Stefano Cosma; Andrea Roberto Carosso; Federica Bevilacqua; Niccolò Gallio; Chiara Benedetto; Leonardo Micheletti
Journal:  Int J Mol Sci       Date:  2020-12-27       Impact factor: 5.923

8.  Prognostic factors and a value of 2009 FIGO staging system in vulvar cancer.

Authors:  Jacek J Sznurkowski; Tomasz Milczek; Janusz Emerich
Journal:  Arch Gynecol Obstet       Date:  2012-12-22       Impact factor: 2.344

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.